Azenta Inc (AZTA)
42.62
-1.88
(-4.24%)
USD |
NASDAQ |
Nov 14, 16:00
42.00
-0.62
(-1.47%)
Pre-Market: 09:23
Azenta Cash from Operations (Quarterly): 1.791M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.791M |
March 31, 2024 | 8.356M |
December 31, 2023 | 26.43M |
September 30, 2023 | 39.91M |
June 30, 2023 | 16.75M |
March 31, 2023 | -12.15M |
December 31, 2022 | -27.02M |
September 30, 2022 | 9.634M |
June 30, 2022 | -419.94M |
March 31, 2022 | -71.36M |
December 31, 2021 | 15.62M |
September 30, 2021 | 27.11M |
June 30, 2021 | 44.80M |
March 31, 2021 | 34.21M |
December 31, 2020 | 43.73M |
September 30, 2020 | 51.80M |
June 30, 2020 | 26.12M |
March 31, 2020 | -65.80M |
December 31, 2019 | 25.74M |
September 30, 2019 | 32.66M |
June 30, 2019 | 36.01M |
March 31, 2019 | 15.96M |
December 31, 2018 | 6.264M |
September 30, 2018 | 31.21M |
June 30, 2018 | 19.33M |
Date | Value |
---|---|
March 31, 2018 | 20.21M |
December 31, 2017 | 3.216M |
September 30, 2017 | 34.84M |
June 30, 2017 | 18.08M |
March 31, 2017 | 24.59M |
December 31, 2016 | 18.71M |
September 30, 2016 | 23.44M |
June 30, 2016 | 15.74M |
March 31, 2016 | 12.75M |
December 31, 2015 | -12.38M |
September 30, 2015 | 22.26M |
June 30, 2015 | 16.52M |
March 31, 2015 | 1.918M |
December 31, 2014 | 3.035M |
September 30, 2014 | 13.44M |
June 30, 2014 | 4.687M |
March 31, 2014 | 27.18M |
December 31, 2013 | 8.473M |
September 30, 2013 | 24.75M |
June 30, 2013 | 12.89M |
March 31, 2013 | 11.63M |
December 31, 2012 | 5.112M |
September 30, 2012 | 3.464M |
June 30, 2012 | 10.88M |
March 31, 2012 | 16.59M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-419.94M
Minimum
Jun 2022
51.80M
Maximum
Sep 2020
-11.80M
Average
16.75M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
Bruker Corp | 38.40M |
Harvard Bioscience Inc | -0.842M |
Bionano Genomics Inc | -20.98M |
Akoya Biosciences Inc | -11.04M |
Singular Genomics Systems Inc | -18.04M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 201.62M |
Cash from Financing (Quarterly) | -224.44M |
Free Cash Flow | 40.93M |
Free Cash Flow Per Share (Quarterly) | -0.0907 |
Free Cash Flow to Equity (Quarterly) | -4.802M |
Free Cash Flow to Firm (Quarterly) | -4.802M |
Free Cash Flow Yield | 1.71% |